CN1193626A - 抗坏血酸单磷酸酯盐的制造方法 - Google Patents
抗坏血酸单磷酸酯盐的制造方法 Download PDFInfo
- Publication number
- CN1193626A CN1193626A CN98105706A CN98105706A CN1193626A CN 1193626 A CN1193626 A CN 1193626A CN 98105706 A CN98105706 A CN 98105706A CN 98105706 A CN98105706 A CN 98105706A CN 1193626 A CN1193626 A CN 1193626A
- Authority
- CN
- China
- Prior art keywords
- xitix
- salt
- formula
- reaction
- alkali
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 ascorbyl monophosphates Chemical class 0.000 title claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 9
- 150000003839 salts Chemical class 0.000 claims abstract description 70
- 238000006243 chemical reaction Methods 0.000 claims abstract description 41
- 230000026731 phosphorylation Effects 0.000 claims abstract description 37
- 238000006366 phosphorylation reaction Methods 0.000 claims abstract description 37
- 238000000034 method Methods 0.000 claims abstract description 35
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 25
- 239000000203 mixture Substances 0.000 claims abstract description 24
- UGTZMIPZNRIWHX-UHFFFAOYSA-K sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 claims abstract description 23
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 9
- 239000007864 aqueous solution Substances 0.000 claims abstract description 8
- 229920000388 Polyphosphate Polymers 0.000 claims description 47
- 239000001205 polyphosphate Substances 0.000 claims description 47
- 239000003513 alkali Substances 0.000 claims description 27
- 150000000994 L-ascorbates Chemical class 0.000 claims description 26
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 20
- 238000001035 drying Methods 0.000 claims description 15
- 235000011176 polyphosphates Nutrition 0.000 claims description 13
- 239000000920 calcium hydroxide Substances 0.000 claims description 12
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 12
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 claims description 8
- 238000005507 spraying Methods 0.000 claims description 8
- 229910001420 alkaline earth metal ion Inorganic materials 0.000 claims description 5
- 239000012429 reaction media Substances 0.000 claims description 5
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims description 4
- 229910001413 alkali metal ion Inorganic materials 0.000 claims description 3
- 229910052728 basic metal Inorganic materials 0.000 claims description 3
- 150000003818 basic metals Chemical class 0.000 claims description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract description 34
- 229910019142 PO4 Inorganic materials 0.000 abstract description 8
- 239000010452 phosphate Substances 0.000 abstract description 8
- 150000003013 phosphoric acid derivatives Chemical class 0.000 abstract description 8
- 239000006227 byproduct Substances 0.000 abstract description 6
- 229960005070 ascorbic acid Drugs 0.000 abstract description 4
- 229910052784 alkaline earth metal Chemical class 0.000 abstract description 3
- 241000251468 Actinopterygii Species 0.000 abstract description 2
- 241001465754 Metazoa Species 0.000 abstract description 2
- 239000000654 additive Substances 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 230000003647 oxidation Effects 0.000 abstract description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- 230000015556 catabolic process Effects 0.000 abstract 2
- 238000006731 degradation reaction Methods 0.000 abstract 2
- 239000002211 L-ascorbic acid Substances 0.000 abstract 1
- 235000000069 L-ascorbic acid Nutrition 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 238000007865 diluting Methods 0.000 abstract 1
- 235000020939 nutritional additive Nutrition 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 235000011116 calcium hydroxide Nutrition 0.000 description 17
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 15
- 229960005055 sodium ascorbate Drugs 0.000 description 15
- 229910052757 nitrogen Inorganic materials 0.000 description 14
- 235000010378 sodium ascorbate Nutrition 0.000 description 14
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 235000011121 sodium hydroxide Nutrition 0.000 description 6
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 6
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 5
- 235000011941 Tilia x europaea Nutrition 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 239000004571 lime Substances 0.000 description 5
- 150000004712 monophosphates Chemical class 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- 229940083608 sodium hydroxide Drugs 0.000 description 5
- 238000009834 vaporization Methods 0.000 description 5
- 230000008016 vaporization Effects 0.000 description 5
- 239000003643 water by type Substances 0.000 description 5
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 101000628535 Homo sapiens Metalloreductase STEAP2 Proteins 0.000 description 3
- 102100026711 Metalloreductase STEAP2 Human genes 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 239000004570 mortar (masonry) Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 235000017550 sodium carbonate Nutrition 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 235000019187 sodium-L-ascorbate Nutrition 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 235000019733 Fish meal Nutrition 0.000 description 2
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000004467 fishmeal Substances 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 2
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108050008598 Phosphoesterases Proteins 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- MPRIPRKYELTAHA-UHFFFAOYSA-N [Na].[Ca].P(O)(O)(O)=O Chemical compound [Na].[Ca].P(O)(O)(O)=O MPRIPRKYELTAHA-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- QXJJQWWVWRCVQT-UHFFFAOYSA-K calcium;sodium;phosphate Chemical compound [Na+].[Ca+2].[O-]P([O-])([O-])=O QXJJQWWVWRCVQT-UHFFFAOYSA-K 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 125000005341 metaphosphate group Chemical group 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001149 thermolysis Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Saccharide Compounds (AREA)
- Paper (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Abstract
Description
实施例 | 4 5 6 7 |
水(g)ASC(g)NaOH 28%(g)STMP(g)Ca(OH)2(g)H2SO4(g)Water(g)反应溶液(g) | 50 50 50 50176 176 176 176163.5 166 163.5 163.5132.6 112.2 102 91.837 37 37 33.34 8.8 104 8.9200 200 200 200763.1 750 738.9 723.5 |
温度(℃)NaASC溶液的pH值加入STMP/Ca(OH)2时间进一步搅拌时间 | 40-60 40 40-60 40-609.9 10 10 102h 4h 2h 2h0.25h 1h 0.25h 0.25h |
HPLC分析(ASC抗坏血酸等当量ASC(%)ASC单磷酸酯盐(%)ASC二磷酸酯盐(%)ASC磷酸酯盐总量(%)ASC总量(%) | 5 7.1 8.7 11.431.6 37.9 39.4 38.16.2 2.5 1.2 0.939.3 41.5 41.6 39.644.3 48.6 50.3 51 |
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97104554.7 | 1997-03-18 | ||
EP97104554 | 1997-03-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1193626A true CN1193626A (zh) | 1998-09-23 |
CN1083845C CN1083845C (zh) | 2002-05-01 |
Family
ID=8226611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98105706A Expired - Lifetime CN1083845C (zh) | 1997-03-18 | 1998-03-17 | 抗坏血酸单磷酸酯盐的制造方法 |
Country Status (15)
Country | Link |
---|---|
US (1) | US6063937A (zh) |
EP (1) | EP0866069B1 (zh) |
JP (1) | JP3980157B2 (zh) |
KR (1) | KR100508576B1 (zh) |
CN (1) | CN1083845C (zh) |
AU (1) | AU727119B2 (zh) |
CA (1) | CA2230774C (zh) |
CO (1) | CO5050365A1 (zh) |
DE (1) | DE59806485D1 (zh) |
DK (1) | DK0866069T3 (zh) |
ES (1) | ES2186935T3 (zh) |
HK (1) | HK1016183A1 (zh) |
IS (1) | IS4688A (zh) |
NO (1) | NO322052B1 (zh) |
TW (1) | TW476760B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102239127A (zh) * | 2008-10-06 | 2011-11-09 | 建筑研究和技术有限公司 | 磷酸化缩聚产物、其制备方法及用途 |
CN102702264A (zh) * | 2012-05-28 | 2012-10-03 | 石药集团维生药业(石家庄)有限公司 | 一种饲料级l-抗坏血酸-2-磷酸酯盐的制备方法 |
CN103113406A (zh) * | 2012-11-14 | 2013-05-22 | 江苏江山制药有限公司 | 一种磷酸-2-抗坏血酸酯盐的制备方法 |
CN103524558A (zh) * | 2013-10-25 | 2014-01-22 | 东北制药集团股份有限公司 | 一种维生素c-2-磷酸酯盐的制备方法 |
CN103396442B (zh) * | 2013-08-21 | 2015-09-09 | 安徽天寅生物技术有限公司 | 水溶性维生素c偏磷酸钠钙及其制备方法 |
CN105481895A (zh) * | 2015-11-26 | 2016-04-13 | 帝斯曼江山制药(江苏)有限公司 | 一种高纯度Vc-2-单磷酸酯钠的制备方法以及由此制备的高纯度Vc-2-单磷酸酯钠产品 |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2230774C (en) * | 1997-03-18 | 2007-06-26 | F. Hoffmann-La Roche Ag | Manufacture of ascorbyl monophosphates |
US6388098B1 (en) | 1999-03-18 | 2002-05-14 | Showa Denko Kabushiki Kaisha | Process for preparing ascorbic acid-2-monophosphate salt |
US6299912B1 (en) * | 1999-04-23 | 2001-10-09 | Showa Denko Kabushiki Kaisha | Preparation for administration to animals and feeding method thereof |
JP2000302683A (ja) * | 1999-04-23 | 2000-10-31 | Showa Denko Kk | 動物投与剤および飼育方法 |
ATE228525T1 (de) | 1999-06-07 | 2002-12-15 | Hoffmann La Roche | Verfahren zur reinigung l-ascorbyl 2-monophosphat |
JP3957195B2 (ja) * | 2001-01-24 | 2007-08-15 | ブライトスマイル プロフェッショナル インク. | 局所用口腔ケア組成物 |
WO2002070531A1 (en) * | 2001-03-02 | 2002-09-12 | Showa Denko K.K. | Ascorbic acid 2-phosphate metal salt with low calcium content |
EP2297377B1 (en) | 2008-05-30 | 2017-12-27 | Colorado State University Research Foundation | Plasma-based chemical source device and method of use thereof |
US8994270B2 (en) | 2008-05-30 | 2015-03-31 | Colorado State University Research Foundation | System and methods for plasma application |
JP2011521735A (ja) | 2008-05-30 | 2011-07-28 | コロラド ステート ユニバーシティ リサーチ ファンデーション | プラズマを発生させるためのシステム、方法、および装置 |
US8222822B2 (en) | 2009-10-27 | 2012-07-17 | Tyco Healthcare Group Lp | Inductively-coupled plasma device |
CA2794902A1 (en) | 2010-03-31 | 2011-10-06 | Colorado State University Research Foundation | Liquid-gas interface plasma device |
EP2554028B1 (en) | 2010-03-31 | 2016-11-23 | Colorado State University Research Foundation | Liquid-gas interface plasma device |
US9532826B2 (en) | 2013-03-06 | 2017-01-03 | Covidien Lp | System and method for sinus surgery |
US9555145B2 (en) | 2013-03-13 | 2017-01-31 | Covidien Lp | System and method for biofilm remediation |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179445A (en) * | 1976-05-06 | 1979-12-18 | Kansas State University Research Foundation | Method of preparation of 2-phosphate esters of ascorbic acid |
US4647672A (en) * | 1985-06-25 | 1987-03-03 | Kansas State University Research Foundation | Ascorbate 2-polyphosphate esters and method of making same |
DE3909198A1 (de) * | 1989-03-21 | 1990-09-27 | Basf Ag | Verfahren zur herstellung von ascorbinsaeure-2-phosphat sowie von 5,6-isorpropyliden-ascorbinsaeure als ausgangsprodukt |
CA2054743C (en) * | 1990-03-07 | 2001-11-20 | Horst Pauling | Method for preparing derivatives of ascorbic acid |
ATE141922T1 (de) * | 1991-04-10 | 1996-09-15 | Hoffmann La Roche | Trocknungsverfahren zur herstellung von ascorbinsäure-2-monophosphaten |
US5110950A (en) * | 1991-06-12 | 1992-05-05 | Kansas State University Research Foundation | Method of preparing 2-phosphorylated compounds of ascorbic acid |
DE4226625A1 (de) * | 1992-08-12 | 1994-02-17 | Basf Ag | Verfahren zur Herstellung von Calcium-L-ascorbat-2-phosphat |
CA2230774C (en) * | 1997-03-18 | 2007-06-26 | F. Hoffmann-La Roche Ag | Manufacture of ascorbyl monophosphates |
-
1998
- 1998-03-02 CA CA002230774A patent/CA2230774C/en not_active Expired - Fee Related
- 1998-03-13 JP JP06237098A patent/JP3980157B2/ja not_active Expired - Lifetime
- 1998-03-14 ES ES98104657T patent/ES2186935T3/es not_active Expired - Lifetime
- 1998-03-14 DE DE59806485T patent/DE59806485D1/de not_active Expired - Lifetime
- 1998-03-14 EP EP98104657A patent/EP0866069B1/de not_active Expired - Lifetime
- 1998-03-14 DK DK98104657T patent/DK0866069T3/da active
- 1998-03-16 IS IS4688A patent/IS4688A/is unknown
- 1998-03-16 CO CO98014527A patent/CO5050365A1/es unknown
- 1998-03-16 NO NO19981166A patent/NO322052B1/no not_active IP Right Cessation
- 1998-03-17 KR KR1019980009018A patent/KR100508576B1/ko not_active IP Right Cessation
- 1998-03-17 CN CN98105706A patent/CN1083845C/zh not_active Expired - Lifetime
- 1998-03-17 US US09/040,210 patent/US6063937A/en not_active Expired - Lifetime
- 1998-03-17 AU AU59345/98A patent/AU727119B2/en not_active Ceased
- 1998-03-17 TW TW087103958A patent/TW476760B/zh not_active IP Right Cessation
-
1999
- 1999-03-23 HK HK99101164A patent/HK1016183A1/xx not_active IP Right Cessation
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102239127A (zh) * | 2008-10-06 | 2011-11-09 | 建筑研究和技术有限公司 | 磷酸化缩聚产物、其制备方法及用途 |
CN102239127B (zh) * | 2008-10-06 | 2014-08-06 | 建筑研究和技术有限公司 | 磷酸化缩聚产物、其制备方法及用途 |
CN102702264A (zh) * | 2012-05-28 | 2012-10-03 | 石药集团维生药业(石家庄)有限公司 | 一种饲料级l-抗坏血酸-2-磷酸酯盐的制备方法 |
CN102702264B (zh) * | 2012-05-28 | 2015-07-15 | 石药集团维生药业(石家庄)有限公司 | 一种饲料级l-抗坏血酸-2-磷酸酯盐的制备方法 |
CN103113406A (zh) * | 2012-11-14 | 2013-05-22 | 江苏江山制药有限公司 | 一种磷酸-2-抗坏血酸酯盐的制备方法 |
CN103396442B (zh) * | 2013-08-21 | 2015-09-09 | 安徽天寅生物技术有限公司 | 水溶性维生素c偏磷酸钠钙及其制备方法 |
CN103524558A (zh) * | 2013-10-25 | 2014-01-22 | 东北制药集团股份有限公司 | 一种维生素c-2-磷酸酯盐的制备方法 |
CN103524558B (zh) * | 2013-10-25 | 2016-05-11 | 东北制药集团股份有限公司 | 一种维生素c-2-磷酸酯盐的制备方法 |
CN105481895A (zh) * | 2015-11-26 | 2016-04-13 | 帝斯曼江山制药(江苏)有限公司 | 一种高纯度Vc-2-单磷酸酯钠的制备方法以及由此制备的高纯度Vc-2-单磷酸酯钠产品 |
CN105481895B (zh) * | 2015-11-26 | 2018-05-04 | 帝斯曼江山制药(江苏)有限公司 | 一种高纯度Vc-2-单磷酸酯钠的制备方法以及由此制备的高纯度Vc-2-单磷酸酯钠产品 |
Also Published As
Publication number | Publication date |
---|---|
DE59806485D1 (de) | 2003-01-16 |
JPH10265489A (ja) | 1998-10-06 |
KR100508576B1 (ko) | 2006-01-27 |
CN1083845C (zh) | 2002-05-01 |
CA2230774A1 (en) | 1998-09-18 |
ES2186935T3 (es) | 2003-05-16 |
DK0866069T3 (da) | 2003-03-24 |
JP3980157B2 (ja) | 2007-09-26 |
CO5050365A1 (es) | 2001-06-27 |
EP0866069B1 (de) | 2002-12-04 |
EP0866069A3 (de) | 2000-02-23 |
TW476760B (en) | 2002-02-21 |
HK1016183A1 (en) | 1999-10-29 |
EP0866069A2 (de) | 1998-09-23 |
US6063937A (en) | 2000-05-16 |
IS4688A (is) | 1998-09-19 |
AU5934598A (en) | 1998-09-24 |
KR19980080363A (ko) | 1998-11-25 |
NO981166D0 (no) | 1998-03-16 |
CA2230774C (en) | 2007-06-26 |
NO981166L (no) | 1998-09-21 |
AU727119B2 (en) | 2000-11-30 |
NO322052B1 (no) | 2006-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1083845C (zh) | 抗坏血酸单磷酸酯盐的制造方法 | |
RU2402523C2 (ru) | Способ получения диформиата натрия | |
CN1705682A (zh) | 水溶性铁碳水化合物复合体、其制备以及包含其的药物 | |
CA2238474A1 (en) | Melamine polymetaphosphate and process for its production | |
CA1328189C (en) | Preparation of tricalcium phosphate | |
KR19990035845A (ko) | 인산-아미노산-다가 금속 복합염 및 반추동물용 사료 첨가제조성물 | |
EP0839459B1 (en) | Composition containing readily absorbable calcium and process for producing the same | |
US7833385B2 (en) | Processes of making monohydrate form of magnesium ammonium phosphate and processes of making paper using same | |
CN1159324C (zh) | 一种l-抗坏血酸2-单磷酸酯盐的制备方法 | |
JPH0379290B2 (zh) | ||
CN1830986A (zh) | 一种环己五醇磷酸酯铵盐的制备方法 | |
CN1025858C (zh) | 2-磷酸抗坏血酸酯类的生产方法 | |
US6451361B1 (en) | Alkali metal magnesium phosphate hydrate buffering feed mineral | |
CN103524558A (zh) | 一种维生素c-2-磷酸酯盐的制备方法 | |
CN106317113A (zh) | 一种l‑抗坏血酸‑2‑单磷酸酯的合成方法 | |
Samy et al. | Characterization of nano dicalcium phosphate (ndcp) synthesized by sol-gel method | |
RU2281245C1 (ru) | Способ получения высококонденсированного полифосфата аммония | |
CN1760199A (zh) | 一种制备l-抗坏血酸-2-磷酸酯及其盐的方法 | |
US5582739A (en) | Reduction of the phosphate content in waste water from the preparation of metal salts of ascorbic acid 2-monophosphate | |
CN1276377A (zh) | 提纯l-抗坏血酸2-单磷酸酯的方法 | |
JP2981247B2 (ja) | ピロ燐酸ナトリウムの製造方法 | |
CN102702264A (zh) | 一种饲料级l-抗坏血酸-2-磷酸酯盐的制备方法 | |
JPH0517167B2 (zh) | ||
JP2523182B2 (ja) | リン酸塩の製造方法 | |
CN85107690A (zh) | 植物生长调节剂用的钛-抗坏血酸固体化合物的合成 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: DSM IP ASSET CO., LTD. Free format text: FORMER OWNER: FUEL HA FUMAN-LALUOQI LTD. Effective date: 20040302 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20040302 Address after: Holland Heerlen Patentee after: D Sm IP Assets Limited Address before: Basel Patentee before: F. Hoffmann-La Roche AG |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1021106 Country of ref document: HK |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20020501 |